No Picture
News

Diving deeper into inherited retinal disorders, Novartis gobbles up another bite-sized optogenetics biotech

Right about a year ago, a Novartis team led by Jay Bradner and Cynthia Grosskreutz at NIBR swooped in to scoop up a Cambridge, MA-based opthalmology gene therapy company called Vedere. Their focus was on a rather narrow market niche: inherited retinal dystrophies that include a wide range of genetic…… Click here to view original post… […]

No Picture
News

Immuneering Announces Inclusion in the Russell 2000® Index

CAMBRIDGE, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced that Immuneering Corporation has been selected to be added to the Russell 2000® Index… Click here to view original post… […]

No Picture
News

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies, today announced that it has commenced an underwritten public offering of shares of its common stock and series B… Click here to view original post… […]

No Picture
News

Selecta Biosciences Announces Appointment of Kevin Tan as Chief Financial Officer

WATERTOWN, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced the appointment of Kevin Tan as chief financial officer. Click here to view original post… […]

No Picture
News

Precision Coating Announces Merger with N2 Biomedical to Expand Medical Coatings Platform

HUDSON, Mass.: HUDSON, Mass., Sept. 20, 2021 /PRNewswire/ — Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company. N2 Biomedical, an Ampersand Capital Partners portfolio company, provides nano-engineered surface treatment and… Click here to view original post… […]